BKYI BIO KEY INTERNATIONAL INC
Nasdaq · SEC CIK 1019034 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 156 since 2021-08-16, latest 2026-07-02 16:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Sullivan James David | CLO, SVP Strategy, Compliance | — | — |
| DEPASQUALE MICHAEL W | CEO, Dir, COB | — | — |
| LACOUS MIRA K | CTO | — | — |
Transactions 157
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-15 | 2022-08-12 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +544 | 13.0K | +4% | $0 | |
| 2022-08-15 | 2022-08-12 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +544 | 16.7K | +3% | $0 | |
| 2022-08-12 | 2022-08-11 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +1,383 | 12.5K | +12% | $0 | |
| 2022-08-12 | 2022-08-11 | BKYI | Gilley Thomas | Dir | A - Grant | $0.00 | +1,383 | 14.2K | +11% | $0 | |
| 2022-08-12 | 2022-08-11 | BKYI | Bush, III Thomas | Dir | A - Grant | $0.00 | +1,383 | 14.5K | +11% | $0 | |
| 2022-08-12 | 2022-08-11 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +1,383 | 15.2K | +10% | $0 | |
| 2022-08-12 | 2022-08-11 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +1,383 | 16.2K | +9% | $0 | |
| 2022-07-05 | 2022-06-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $1.50 | +2,500 | 65.5K | +4% | +$3,750 | |
| 2022-07-05 | 2022-06-30 | BKYI | LACOUS MIRA K | CTO | A - Grant | $1.50 | +2,500 | 16.6K | +18% | +$3,750 | |
| 2022-07-05 | 2022-06-30 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | A - Grant | $1.50 | +2,500 | 69.5K | +4% | +$3,750 | |
| MA | 2022-06-28 | 2022-06-13+ | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $1.69 | +3,500 | 62.6K | +6% | +$5,908 |
| M | 2022-06-15 | 2022-06-13+ | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $1.69 | +3,500 | 63.0K | +6% | +$5,908 |
| 2022-06-15 | 2022-06-14 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $1.66 | +2,000 | 67.0K | +3% | +$3,320 | |
| 2022-05-26 | 2022-05-26 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $1.80 | +2,500 | 65.0K | +4% | +$4,500 | |
| 2022-05-26 | 2022-05-16 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +474 | 14.8K | +3% | $0 | |
| 2022-05-18 | 2022-05-16 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +474 | 13.8K | +4% | $0 | |
| 2022-05-18 | 2022-05-16 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +474 | 11.1K | +4% | $0 | |
| 2022-05-16 | 2022-05-12 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +1,539 | 14.3K | +12% | $0 | |
| 2022-05-16 | 2022-05-12 | BKYI | Bush, III Thomas | Dir | A - Grant | $0.00 | +1,539 | 13.1K | +13% | $0 | |
| 2022-05-16 | 2022-05-12 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +1,539 | 13.3K | +13% | $0 | |
| 2022-05-16 | 2022-05-12 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +1,539 | 10.6K | +17% | $0 | |
| 2022-05-16 | 2022-05-12 | BKYI | Gilley Thomas | Dir | A - Grant | $0.00 | +1,539 | 12.8K | +14% | $0 | |
| 2022-04-04 | 2022-03-30 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +414 | 12.8K | +3% | $0 | |
| 2022-04-04 | 2022-03-30 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +414 | 9,102 | +5% | $0 | |
| 2022-04-04 | 2022-03-30 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +414 | 11.8K | +4% | $0 | |
| 2022-03-15 | 2022-03-11 | BKYI | LACOUS MIRA K | CTO | A - Grant | $0.00 | +7,500 | 14.1K | +113% | $0 | |
| 2022-03-15 | 2022-03-11 | BKYI | Kwok Fong Wong | Managing Dir, BIO-key HK, Dir, 10% | A - Grant | $0.00 | +5,000 | 558.0K | +0.9% | $0 | |
| 2022-03-15 | 2022-03-11 | BKYI | Welch Cecilia C | CFO | A - Grant | $0.00 | +30.0K | 34.1K | +727% | $0 | |
| 2022-03-15 | 2022-03-11 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $0.00 | +30.0K | 59.5K | +102% | $0 | |
| 2022-03-15 | 2022-03-11 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | A - Grant | $0.00 | +35.0K | 62.5K | +127% | $0 | |
| M | 2022-03-14 | 2022-03-10+ | BKYI | Bush, III Thomas | Dir | A - Grant | $0.00 | +7,162 | 11.1K | +181% | $0 |
| M | 2022-03-14 | 2022-03-10+ | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +6,738 | 12.4K | +120% | $0 |
| M | 2022-03-14 | 2022-03-10+ | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +6,272 | 3,688 | New | $0 |
| M | 2022-03-14 | 2022-03-10+ | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +6,272 | 6,370 | +6,400% | $0 |
| M | 2022-03-14 | 2022-03-10+ | BKYI | Gilley Thomas | Dir | A - Grant | $0.00 | +6,696 | 11.3K | +146% | $0 |
| 2022-01-04 | 2021-12-31 | BKYI | LACOUS MIRA K | CTO | A - Grant | $1.88 | +2,500 | 6,625 | +61% | +$4,700 | |
| 2022-01-04 | 2021-12-31 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $1.88 | +2,500 | 29.5K | +9% | +$4,700 | |
| 2022-01-04 | 2021-12-31 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | A - Grant | $1.88 | +2,500 | 27.5K | +10% | +$4,700 | |
| 2021-11-30 | 2021-11-29 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $2.55 | +2,500 | 25.0K | +11% | +$6,375 | |
| M | 2021-11-29 | 2021-11-24 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $2.56 | +2,000 | 26.5K | +8% | +$5,125 |
| 2021-11-16 | 2021-11-15 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +162 | 5,620 | +3% | $0 | |
| 2021-11-16 | 2021-11-15 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +162 | 2,416 | +7% | $0 | |
| 2021-11-16 | 2021-11-15 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +162 | 5,098 | +3% | $0 | |
| 2021-11-12 | 2021-11-11 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +323 | 2,254 | +17% | $0 | |
| 2021-11-12 | 2021-11-11 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +323 | 4,936 | +7% | $0 | |
| 2021-11-12 | 2021-11-11 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +323 | 5,458 | +6% | $0 | |
| 2021-11-12 | 2021-11-11 | BKYI | Gilley Thomas | Dir | A - Grant | $0.00 | +323 | 4,574 | +8% | $0 | |
| 2021-11-12 | 2021-11-11 | BKYI | Bush, III Thomas | Dir | A - Grant | $0.00 | +323 | 4,416 | +8% | $0 | |
| M | 2021-08-25 | 2021-08-23+ | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | P - Purchase | $3.09 | +2,000 | 22.5K | +10% | +$6,188 |
| M | 2021-08-20 | 2021-08-19 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | P - Purchase | $2.99 | +5,000 | 25.0K | +25% | +$15.0K |
| 2021-08-17 | 2021-08-16 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +164 | 4,613 | +4% | $0 | |
| 2021-08-17 | 2021-08-16 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +164 | 5,135 | +3% | $0 | |
| 2021-08-16 | 2021-08-12 | BKYI | Alia Emmanuel | Dir | A - Grant | $0.00 | +312 | 1,931 | +19% | $0 | |
| 2021-08-16 | 2021-08-12 | BKYI | Knook Pieter Cornelis | Dir | A - Grant | $0.00 | +312 | 4,449 | +8% | $0 | |
| 2021-08-16 | 2021-08-12 | BKYI | Bush, III Thomas | Dir | A - Grant | $0.00 | +312 | 4,093 | +8% | $0 | |
| 2021-08-16 | 2021-08-12 | BKYI | Michel Robert J | Dir | A - Grant | $0.00 | +312 | 4,971 | +7% | $0 | |
| 2021-08-16 | 2021-08-12 | BKYI | Gilley Thomas | Dir | A - Grant | $0.00 | +312 | 4,251 | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations